Anthropic is making biotech boasts, but scientists are wary of hype around ‘curing cancer’
Top Story
Archived
•
November 6, 2026
•
Anthropic has been pushing is biotechnology projects in a bid to drive up its stock price, but scientists warn people need to be realistic. The AI giant has opened a biology lab in the Bay Area, bought two biotech startups — one for about $400 million in stock — and partnered with drugmakers including Bristol...
Source: New York Post | https://nypost.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



